Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 01-2008 | 12-2007 | 01-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,119 | 28 | 11,471 | 1,276 | 3,646 |
| Marketable Securities | N/A | N/A | 3,944 | N/A | 18,375 |
| Receivables | N/A | 4,622 | 77 | 5,227 | 93 |
| Inventories | 864 | 7,760 | 511 | 5,809 | 957 |
| Income taxes - deferred | N/A | 1,151 | N/A | 1,030 | N/A |
| Other current assets | 0 | 1,712 | 450 | 0 | 0 |
| TOTAL | $7,313 | $15,427 | $16,599 | $13,674 | $23,239 |
| Non-Current Assets | |||||
| PPE Net | 4,877 | 2,127 | 5,290 | 3,340 | 5,344 |
| Investments And Advances | 35 | 0 | 35 | 0 | 35 |
| Intangibles | 969 | 1,254 | 958 | 0 | 857 |
| Other Non-Current Assets | 17 | 2,572 | 260 | 721 | 1,956 |
| TOTAL | $5,898 | $5,953 | $6,543 | $4,061 | $8,192 |
| Total Assets | $13,211 | $21,380 | $23,142 | $17,735 | $31,431 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 5,814 | N/A | 230 | 3,871 |
| Accounts payable and accrued liabilities | 791 | 3,107 | 1,118 | 1,102 | 1,548 |
| Accrued Expenses | 876 | 1,606 | 1,069 | 1,692 | 1,261 |
| Other current liabilities | N/A | 956 | N/A | 933 | N/A |
| TOTAL | $1,667 | $12,997 | $2,187 | $3,986 | $6,680 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 2,334 | N/A |
| aiOther Non-Current Liabilities | 0 | 258 | 0 | 143 | 0 |
| TOTAL | $N/A | $589 | $N/A | $2,483 | $N/A |
| Total Liabilities | $1,667 | $13,586 | $2,187 | $6,469 | $6,680 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 153 | 3,581 | 140 | 3,573 | 132 |
| Common Shares | 79 | 1,605 | 74 | 1,602 | 67 |
| Retained earnings | -197,409 | 4,535 | -185,190 | 8,141 | -167,051 |
| Other shareholders' equity | 0 | -163 | -7 | -163 | 46 |
| TOTAL | $11,544 | $7,794 | $20,955 | $11,266 | $24,751 |
| Total Liabilities And Equity | $13,211 | $21,380 | $23,142 | $17,735 | $31,431 |